Â鶹´«Ã½

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Scrip Pharma Intelligence02:34
PR Newswire (Press Release)08:13
The Motley Fool18:33
Benzinga00:43
ENDPOINTS01:51
pharmaphorum20:11
Benzinga02:19
Yesterday
Scrip Pharma Intelligence02:34 19-Sept-24
In the last 7 days
BioNTech (Press Release)20:46 17-Sept-24
The Motley Fool18:33 17-Sept-24
BioPharma Dive02:18 17-Sept-24
ENDPOINTS01:51 17-Sept-24
Benzinga00:43 14-Sept-24
In the last month
pharmaphorum20:11 12-Sept-24
PR Newswire (Press Release)08:13 12-Sept-24
Benzinga02:19 12-Sept-24
Seeking Alpha21:29 11-Sept-24
FierceBiotech19:44 11-Sept-24
Benzinga04:11 7-Sept-24
Forbes19:58 6-Sept-24
BioNTech (Press Release)21:19 5-Sept-24
GlobeNewswire (Press Release)23:48 4-Sept-24
Business Wire (Press Release)22:33 4-Sept-24
JD Supra04:49 4-Sept-24
Skeptical Raptor07:37 3-Sept-24
UPI10:14 1-Sept-24
Benzinga02:09 30-Aug-24
JD Supra03:54 29-Aug-24
ENDPOINTS01:53 28-Aug-24
FierceBiotech23:33 27-Aug-24
Clinical Trials Arena20:39 26-Aug-24
GlobeNewswire (Press Release)03:33 26-Aug-24
Seeking Alpha04:27 24-Aug-24
FiercePharma01:26 24-Aug-24
IFLScience01:08 24-Aug-24
RTT News22:22 23-Aug-24
PMLiVE21:31 23-Aug-24
pharmaphorum18:34 23-Aug-24
TipRanks06:59 23-Aug-24
Benzinga04:40 23-Aug-24
GlobeNewswire (Press Release)04:19 23-Aug-24
Seeking Alpha07:26 21-Aug-24
Biopharma Reporter01:40 21-Aug-24
Scrip Pharma Intelligence01:39 21-Aug-24
Clinical Trials Arena20:25 20-Aug-24
Hong Kong Standard13:38 20-Aug-24
view more headlines
19 Sept 02:34

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.